Prothena Corporation PLC (PRTA) FinancialsPRTAProthena Corporation PLC

Evaluating the bottom line, Prothena Corporation PLC maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -1850.20%, while the net margin is -1839.90%. These profitability ratios, combined with a Return on Equity (ROE) of -14.39%, provide a clear picture of how effectively PRTA converts its operational activities into shareholder value.

In the context of the broader market, PRTA competes directly with industry leaders such as ALT and CBIO. With a market capitalization of $428.66M, it holds a significant position in the sector. When comparing efficiency, PRTA's gross margin of 100.00% stands against ALT's N/A and CBIO's 100.00%. Such benchmarking helps identify whether Prothena Corporation PLC is trading at a premium or discount relative to its financial performance.

Prothena reported a net income of -18,583,000 USD in Q2 2026, with a forward P/E of 10.627, indicating potential value but ongoing losses.